-----:0
Expresses the sense of the Senate that: (1) the Centers for Disease Control and Prevention (CDC) should identify and collect data on racial disparities in the incidence and prevalence of hypertension, and (2) the Department of Health and Human Services should coordinate the collection and analysis of such data with the National Heart, Lung, and Blood Institute.
-----:1
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide for the conduct and dissemination of an updated review of studies on the methodology and impact of tomato products on prostate cancer incidence and the risk of such cancer.
-----:2
Chronic hcv infection and liver fibrosis: A descriptive study - Amends the Federal Food, Drug, and Cosmetic Act to provide new criteria for treating chronic hcv infection. Defines: (1) "chronic hcv infection" as infection that is mild in serum transaminase levels and does not cause significant clinical symptoms; and (2) "chronic hcv infection" as infection that is elevated in specified serum levels and does not cause significant clinical symptoms. Provides guidelines for treating chronic hcv infection.
-----:3
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration (HRSA), to report to Congress regarding the policies and practices of foreign countries regarding replacement blood donors.
Directs the Secretary to establish a pilot program in the United States for the development and implementation of policies and practices for voluntary blood donor procurement. Requires the Secretary to report to Congress regarding such programs and the extent to which foreign countries are implementing such policies and practices.
-----:4
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to submit to the appropriate congressional committees a report containing: (1) a list of proteins known to have an interaction with a species; (2) a list of proteins known to have an interaction with any other species; and (3) a description of the role of each protein in the interaction.
-----:5
Disulfiram should be used at the lowest effective dose, possibly 250 mg per day, first intake only without any additional requirement of anti - psychotic treatment.
-----:6
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to offer to enter into a cooperative agreement with the governments of Mexico, Canada, and the United States to: (1) identify, test, and develop new strategies to prevent the spread of malfestina, an invasive species of insects, in Mexico; and (2) provide technical assistance to such governments in using prevention and control strategies with respect to such insects. Requires the Secretary to enter into such agreements with the governments of Mexico, Canada, and the United States to: (1) identify, test, and develop new strategies to prevent the spread of malfestina; and (2) provide technical assistance to such governments in using prevention and control strategies with respect to such insects.
-----:7
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to ensure that the data from this study are made available to the public and posted on the CDC website.
-----:8
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the National Institute of Diabetes and Digestive and Kidney Diseases to: (1) conduct research to evaluate the relationship between low levels of srage and development of diabetes; and (2) support the development of new technologies to improve the diagnosis of diabetes.
-----:9
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make grants to eligible public or nonprofit private entities to carry out this study. Authorizes appropriations.
-----:10
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Cancer Institute to conduct a study on the status of small cell carcinoma of the bladder, and to report on the results of such study.
-----:11
Prohibits such syndrome from being considered a disease of the central nervous system.
-----:12
Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the CDC to: (1) monitor the collection and testing of brain and other tissues from patients with medblastoma, (2) monitor and test for the presence or absence of human immunodeficiency virus (HIV) in patients with medblastoma, and (3) conduct basic, clinical, and translational research with respect to medblastoma.
-----:13
Expresses the sense of the Senate that: (1) the Food and Drug Administration (FDA) should issue guidance on the use of bexal antimicrobials, and (2) the Centers for Disease Control and Prevention (CDC) should collect data on the use of bexal antimicrobials and update such guidance as necessary. Amends the Federal Food, Drug, and Cosmetic Act to require the FDA to issue guidance on the use of bexal antimicrobials.
-----:14
femorotabular impingement research - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the CDC with respect to the treatment of femorotabular impingement.
-----:15
Food Security and Nutrition Act of 2012 - Amends the Food, Conservation, and Energy Act of 2008 to authorize the Secretary of Agriculture, acting through the Director of the United States Agency for International Development (USAID), to provide assistance for a pilot program to improve the nutritional status of at-risk five-year old children in salmas district, Afghanistan.

Directs the Secretary to establish a program to provide supplemental nutrition assistance for such children. Sets forth reporting requirements.
-----:16
TABLE OF CONTENTS: 
 Title I: Tay-Sachs 
 Title II: Genetic Epidemiology 
 Title III: Radiological and Medical Research 
Title I: Tay-Sachs
 - Directs the Secretary of Health and Human Services to conduct a study to determine the prevalence and distribution of Tay-Sachs. 
Title II: Genetic Epidemiology
 - Directs the Secretary to conduct a study to determine the prevalence and distribution of Tay-Sachs in children. Authorizes the Secretary to make grants to public or nonprofit private entities for the purpose of conducting this study.
-----:17
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an arrangement with the National Cancer Institute to study and report to Congress on the treatment of individuals with primary cutaneous malignant melanoma.
-----:18
TABLE OF CONTENTS: 
 Title I: General Provisions 
 Title II: Provisions 
 Title III: Special Provisions 
 Title IV: Effective Dates 
Title I: General Provisions
 - Provides that the provisions of this title shall apply to all authorities under the laws of the United States, including but not limited to the Secretary of Health and Human Services, the Director of the National Institutes of Health, and the Secretary of Agriculture. 
Title II: Provisions
 - Provides that the provisions of this title shall apply to all authorities under the laws of the United States, including but not limited to the Secretary of Health and Human Services, the Director of the National Institutes of Health, and the Secretary of Agriculture. 
Title III: Special Provisions
 - Provides that the provisions of this title shall apply to all authorities under the laws of the United States, including but not limited to the Secretary of Health and Human Services, the Director of the National Institutes of Health, and the Secretary of Agriculture.
-----:19
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to convene a panel of experts to review and make recommendations on the current state of the science relating to the diagnosis of pji (total joint infection) and how it may be improved. Requires the Secretary to: (1) review this panel's recommendations at least once every five years; and (2) report to the public on the review's findings and recommendations.
-----:20
Expresses the sense of the Congress that: (1) the Food and Drug Administration should issue specific guidance on the use of certain chemotherapy agents to reduce the risk of adverse events in patients receiving such drugs; and (2) the Centers for Disease Control and Prevention should conduct a study to determine the prevalence and incidence of adverse events with respect to such drugs.
-----:21
Directs the Secretary of Health and Human Services to establish a grant program to support research, development, demonstration, and application of new materials and technologies for the prevention and control of dental caries. Authorizes appropriations.
-----:22
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to offer to enter into an agreement with the National Academy of Sciences to review the current state of knowledge about the role of certain protein sequences within the nuclear envelope of human cells.
-----:23
Microbicide Research Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to submit to the appropriate congressional committees a report containing recommendations on the use of certain macrolideerythromycins for the prevention of infectious diseases.

Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA), to report to the appropriate congressional committees on the use of certain macrolides for such purposes.
-----:24
This report describes a case of pseudozymais fung infiltration, which was reported as an invasive result of chemotherapy after reinduction of the blood drug cytarabine.
-----:25
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide assistance to the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to conduct and support research into: (1) the relationship between diabetic foot ulcerations and complications of kidney disease; (2) the relationship between diabetic foot ulcerations and severe renal disease; and (3) the relationship between diabetic foot ulcerations and end stage renal disease.
-----:26
Authorizes the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to enter into cooperative agreements with the National Heart, Lung, and Blood Institute to: (1) conduct basic, clinical, and translational research to evaluate the role of the sigma1180v gene in the development of heart disease; and (2) provide technical assistance to the Institute to support such research.
Directs the Secretary, acting through the Director of the CDC, to: (1) conduct a basic, clinical, and translational research to evaluate the role of the sigma1180v gene in the development of heart disease; and (2) provide technical assistance to the Institute to support such research.
-----:27
Patients with chronic retinal detachments who should have their retinal detachments best done during working hours and who may be difficult to predict due to poor views, may be difficult to evaluate, and may be difficult to treat.
-----:28
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate activities of the Centers with respect to the research, prevention, and treatment of human disease.
-----:29
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide technical assistance to the Director of the Centers for Disease Control and Prevention (CDC) in designing and implementing this study.
-----:30
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and analyze data on the impact of additive manufacturing methods on the production of dental prostheses, and (2) establish a system to collect and analyze such data.
Directs the Secretary, acting through the Director of the CDC, to: (1) collect and analyze data on the impact of additive manufacturing methods on the production of dental prostheses; and (2) establish a system to collect and analyze such data.
-----:31
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to conduct a study to determine the incidence and prevalence of certain conditions affecting human hair.
-----:32
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and analyze data on the course and incidence of cardiac toxicity in patients with relapsing multiple sclerosis who received mitoxantrone therapy during the period beginning on January 1, 2004, and ending on June 1, 2008; and (2) report on such data to the appropriate congressional committees.
-----:33
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to provide technical assistance to the Director of the National Institute of Diabetes and Digestive and Kidney Diseases in the development and implementation of a plan to improve the quality of health care in the United States.
-----:34
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate research programs to: (1) evaluate the relationship between vitamin d levels and liver inflammation; and (2) evaluate the role of vitamin d on the development of chronic liver diseases.
-----:35
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the Institute of Medicine to conduct a study on the safety and effectiveness of the use of a laser therapy to treat prostate cancer.
-----:36
(This measure has not been amended since it was reported to the Institute of Medicine on June 22, 2012. The summary of that version is repeated here.
-----:37
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to enter into an agreement with the National Academy of Sciences (NAS) to review the current state of knowledge about certain proteins that are important in the genome of human and other animals. Authorizes the Secretary to: (1) enter into such agreements to study those proteins in more detail, and (2) use the results of those studies to develop new approaches to target those proteins.
-----:38
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an arrangement with the National Cancer Institute to study and report to the Secretary and the public on the costs and benefits associated with screening and treatment of individuals with melanoma.
-----:39
Directs the Secretary, acting through the Director of the National Institutes of Health (NIH), to expand, intensify, and coordinate the research programs of the NIH related to the use of neurotrophic factors to prevent and treat various forms of blindness.
-----:40
Authorizes the Secretary of Health and Human Services to provide grants to eligible public or nonprofit private entities to carry out research relating to the diagnosis, prevention, and treatment of biliary hamartomas. Authorizes appropriations.
-----:41
Human Rights Protection Act of 2016 This bill authorizes the President to provide assistance, including through multilateral, nongovernmental, and faith-based organizations, to promote and protect the human rights of people whose rights are not on the basis of their gender identity or gender identity because of their sexual orientation or gender identity. It expresses the sense of the Congress that the President, acting through the United States Agency for International Development (USAID), should: review USAID's support for activities to protect the human rights of people whose rights are not on the basis of their gender identity or gender identity to determine whether it can be used to assist in achieving universal access to health care and prevention of hiv and hepatitis virus infections in Nigeria; and support activities to protect the human rights of people whose rights are not on the basis of their gender identity or gender identity because of their sexual orientation or gender identity. It expresses the sense of the Congress that the United States should support efforts to protect the human rights of people whose rights are not on the basis of their gender identity or gender identity because of their sexual orientation or gender identity.
-----:42
Long-Term Care Insurance Program in Korea - Amends title XVIII (Medicare) of the Social Security Act, as amended by the Health Insurance Portability and Accountability Act of 1996 (HIPAA), to require the Secretary of Health and Human Services (HHS) to provide for the establishment of a long-term care (LTC) insurance program in korea.

Defines LTC insurance as life insurance for LTC facilities that provide care and services to individuals over the age of 65.

Requires the Secretary to establish: (1) a list of drugs and biologics that may be considered potentially inappropriate for use in elderly patients, (2) a formula for determining the appropriate LTC grade for each LTC facility, and (3) quality of care standards for each facility.
-----:43
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to provide assistance to develop and implement a comprehensive strategy to reduce the incidence and mortality rates of extrahec portal hypertension (evosplenism) around the world by carrying out activities to improve the diagnosis, prevention, and treatment of such disease. Authorizes appropriations.
-----:44
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into agreements with the National Heart, Lung, and Blood Institute and the Institute of Diabetes and Digestive and Kidney Diseases of the Health Resources and Services Administration of the Department of Health and Human Services, for the purpose of carrying out research designed to improve the quality of life for individuals with heart disease.
-----:45
Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to convene a panel of experts to review and make recommendations on the current state of science regarding the relationship between obesity, cardiovascular disease, and certain tissue features of men and women.

Directs the Secretary to: (1) convene a panel of experts to review and make recommendations on the current state of science regarding the relationship between obesity, cardiovascular disease, and certain tissue features of men and women; and (2) report to the Congress on those recommendations.
-----:46
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to provide for the conduct of a study to determine the role of educational intervention (patient-based teaching) to improve the prescribing skill of second-year medical students.
-----:47
Expresses the sense of the Senate that the Secretary of Health and Human Services should fully consider the following factors in determining the cause of the pulmonary tuberculosis outbreak in Washington, D.C., in 2003 and 2004: (1) the extent to which illicit drug use may be a factor; (2) the extent to which individuals in Washington, D.C., who contracted pulmonary tuberculosis during 2003 and 2004 were involved in illicit drug use; (3) the extent to which individuals in Washington, D.C., who contracted pulmonary tuberculosis during 2003 and 2004 were involved in illicit drug use; and (4) measures to reduce the incidence of pulmonary tuberculosis in Washington, D.C., in the future.

Authorizes the Secretary to enter into agreements with the National Heart, Lung, and Blood Institute and the Institute of Medicine to conduct epidemiologic research regarding pulmonary tuberculosis in Washington, D.C.
-----:48
Instructs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and review data on hospital-acquired vancomycin resistance to determine the extent to which such resistance is associated with hospital-acquired vancomycin failure; (2) undertake further studies to determine the extent to which such resistance is associated with hospital-acquired vancomycin failure; and (3) report findings to the appropriate congressional committees.
-----:49
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and analyze data on the use of villiptin (Voluntary Prescription Drug Benefit Program) by individuals with diabetes, and (2) report such data to the National Institutes of Health (NIH).
-----:50
2010oc 2010 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to increase the number of specimens analyzed for enterovirus infections in the National Institute of Allergy and Infectious Diseases.

Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) increase the number of specimens analyzed for enterovirus in the National Institute of Allergy and Infectious Diseases; and (2) conduct activities to increase the number of specimens analyzed for enterovirus.
-----:51
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make grants to eligible public or nonprofit private entities to carry out a program to educate the public and health care providers about dysphagia, and the treatment of such condition. Authorizes appropriations.
-----:52
Directs the Secretary of Health and Human Services to ensure that the National Institute of Diabetes and Digestive and Kidney Diseases shall continue to carry out research relating to the use of innovative technologies in the treatment of colorectal injuries.
-----:53
Drug Delivery System - Provides for the delivery of drugs through a delivery system using an electrical barrier which maintains a constant thickness across the delivery mechanisms of the drug.
-----:54
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide for a study on the impact of physical exercise on rheumatoid arthritis patients.
-----:55
TABLE OF CONTENTS: 
 Title I: Scientific Review 
 Title II: Public Health Impact 
 Title III: Food Amendments 
Food Amendments of 1993 - 
Title I: Science Review
 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to conduct a scientific review of the current state of science regarding the impact of food on human health. Requires the Secretary to: (1) review the current state of science regarding the impact of food on human health; (2) evaluate the current state of science regarding the impact of food on human health; and (3) report to the Congress. 
Title II: Public Health Impact
 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to provide for a scientific review of the current state of science regarding the impact of food on human health. 
Title III: Food Amendments of 1993
 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to provide for a scientific review of the current state of science regarding the impact of food on human health. 
Directs the Secretary to report to the Congress.
-----:56
Directs the Secretary of Health and Human Services, acting through the Agency for Healthcare Research and Quality, to expand, intensify, and coordinate activities of the Centers for Disease Control and Prevention (CDC) related to the research, prevention, and treatment of heart, blood vessel, lung, and muscle diseases.
-----:57
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Heart, Lung, and Blood Institute to conduct a study on the accuracy of the method of collecting and reporting meningioma tissue samples.
-----:58
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect, analyze, and make available to the public data on the incidence and prevalence of pneumoconiosis, including data on treatment options, in the United States and internationally; and (2) determine the incidence and prevalence of pneumoconiosis in the United States and internationally.
-----:59
Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to report to the appropriate congressional committees on the stability of analytes in serum used in clinical laboratories.
-----:60
United States Food and Nutrition Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to add certain information relating to the consumption of milk by individuals under the age of 18 years old that may be reported to the Food and Drug Administration by the Secretary of Health and Human Services.
-----:61
Use of the smart database to collect data on the number of each conserved domain in each five- genome.
-----:62
Tuberculosis Research Act of 2010 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the CDC related to the collection and analysis of data on tuberculosis.

Requires the Director of the CDC, in carrying out activities to increase awareness of tuberculosis, to: (1) increase the number of surveillance sites; (2) expand the scope of activities for which data are available; and (3) coordinate activities with the Director of the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH).
-----:63
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Cancer Institute to conduct a study to evaluate the efficacy and safety of once-daily administration of pde5-is, administered by an experienced prostate cancer surgeon, for the treatment of prostate cancer.
-----:64
Requires the National Institute of Standards and Technology to report on multi-color qd lasers using implantation induced intermixing.
-----:65
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to report to Congress on the status of the use of lincomycin and pirlindycin as antimicrobial drugs.
-----:66
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to report to the Congress on the status of the evidence relating to the effectiveness of the combination of chemotherapy and fluorouracil in patients with advanced penile cancer.
-----:67
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities related to the prevention and control of human hook infection.
-----:68
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) undertake a comprehensive study to determine the prevalence and clinical characteristics of ovov and whether it is the cause of severe pediatric gastroenteritis in countries with a high incidence of such infections; and (2) report the results of such study to the Congress.
-----:69
Multicystic dysplastic kidney syndrome is a dominant condition that causes abnormalities of the kidney and is associated with other multisystemic disorders.
-----:70
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to convene a panel of experts to review the current state of the science relating to the use of blood clotting factors as a risk assessment for cardiovascular disease.
-----:71
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to report to the appropriate congressional committees on the status of the development of antiangiogenic therapy based upon certain biomarkers.
-----:72
(This measure has not been amended since it was reported to the House on May 14, 2014. This measure has not been amended since it was reported to the House on May 14, 2014.
-----:73
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make available to the public: (1) information on the safety and effectiveness of intravitreal injections of a specified drug for the treatment of age-related retinal degeneration; and (2) assistance in disseminating such information to health care providers.
-----:74
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to: (1) collect and analyze data on the impact of glass ionomers used in home dental bleaching products on the release of hydrogen, carbamide, and fluoride into water; and (2) prepare a report on such impact at the Centers.
-----:75
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the Institute of Medicine to conduct a study to review the current state of knowledge about the effectiveness and safety of the flexible brooscopy procedure. Requires the Secretary to report to the appropriate congressional committees on the study and to make recommendations for appropriate improvements in the performance of such procedure.
-----:76
metabolic syndrome is a simple measure of risk factors for diabetes and cardiovascular disease that is used to determine the prevalence of metabolic syndrome in the Indian population.
-----:77
Directs the Secretary, acting through the Director of the Centers for Disease Control and Prevention, to report to the appropriate congressional committees on the status of the research efforts of the Department of Health and Human Services regarding rheumatoid arthritis.
-----:78
Expresses the sense of the Congress that the Department of Health and Human Services should provide for the conduct and support of research into the relationship between dietary intake of soy products and the development of prostate cancer in American men.
-----:79
This bill directs the National Institutes of Health (NIH) to expand, intensify, and coordinate research efforts to: (1) identify new risk or protective factors associated with micrornablastoma, (2) evaluate the efficacy of targeted therapies against such cancer, and (3) identify new targets of therapy for such cancer.
-----:80
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to convene a panel of experts to review and make recommendations on: (1) ablative laser treatment that may be used to reduce and prevent skin aging, and (2) other methods to reduce and prevent skin aging.
-----:81
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to convene a panel of experts to review the current state of the analytical method for determining concentration with high sensitivity of cardiac biomarkers in patients with acute coronary syndrome, and to submit recommendations to the Secretary for improvements in such method.
-----:82
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to provide for the conduct and support of research by the Department of Health and Human Services on the diagnosis, prevention, and treatment of pancreatic cancer.
-----:83
Laboratory Safety Act of 1993 - Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide for the establishment of a national database on laboratory errors that occur during the testing phase of point-of-care (poct) tests.
-----:84
Amends the Higher Education Act of 1965 to authorize the Secretary of Education to make grants to institutions of higher education for research to determine the incidence and prevalence of physical injuries among students who participate in sports programs at such institutions. Authorizes appropriations.
-----:85
Common Sense Medical Malpractice Reform Act of 2009 - States that it is the policy of the United States that, upon the recommendation of the Director of the Agency for Healthcare Research and Quality, it shall be unlawful for any physician or other employee of the United States to withhold from any patient admitted to a hospital, or to require such a physician or employee to withhold from any patient admitted to a hospital, if the physician or employee has reason to believe that the patient is perishable or that the patient may die.

Authorizes the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants to public and nonprofit private entities to carry out research to improve the quality of care provided to patients following cardiac arrest, with an emphasis on the use of therapeutic hypothermia.
-----:86
Nuclear Regulatory Commission Act of 1978 - Directs the Secretary of Energy, acting through the Director of the Nuclear Regulatory Commission (NRC), to submit to the Congress a comprehensive plan for the long-term ( 10 year) storage of high level nuclear wastes in the deep subsurface through the use of multibarrier design techniques.
-----:87
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants to, or enter into contracts with, public or nonprofit private entities to carry out this study. Authorizes appropriations.
-----:88
Expresses the sense of the Congress that: (1) the Food and Drug Administration should comprehensively review the scientific evidence relating to the safety and effectiveness of vitamin E supplementation in women's bodies; and (2) the Department of Health and Human Services should promulgate regulations to ensure that women are provided with accurate information about the safety and effectiveness of vitamin E supplementation in women's bodies.
-----:89
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Academy of Sciences to review the scientific evidence relating to the use of ophthalmologic agents in the treatment of amblyopia, and to submit a report to the Congress.
-----:90
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide assistance to the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate research programs related to asthma and migraine.
-----:91
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate research programs to: (1) improve the safety of bracket bonding techniques; and (2) evaluate the effectiveness of new bracket bonding technologies.
-----:92
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate activities of the Centers for Disease Control and Prevention in order to: (1) monitor and analyze the impact of changes in bone density, including savesay savesay, on the health of individuals with hereditary bone diseases; (2) monitor the impact of changes in bone density, including savesay, on the health of individuals with hereditary bone diseases; and (3) conduct related research with respect to such diseases.
-----:93
Requires the Secretary, acting through the Director of the National Institutes of Health, to report to the appropriate congressional committees regarding the extent to which the variations reported in this report are consistent with the results of other research on cnvs from representative populations.
-----:94
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the Institute of Medicine to conduct a study on the role of certain transcription factors in the pathogenesis of secondary brain injury after traumatic injury.
-----:95
Big Data in Critical Care discusses the use of data in critical care with a focus on the big data that is sweep of digital medical information that has accumulated in the clinical setting and the use of scoring systems to assess the severity of acute care.
-----:96
Prohibits the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), from establishing or enforcing standards for the collection of antibiogram data from hospitals for which specified antimicrobial agents are used.
-----:97
Preliminary results from the 2010 H1n1 pandemic influenza surveillance study are described.
-----:98
bilateral shoulder dislocations are the most type of injury without any traumatic seizure disorder and involve only certain cases of such injury.
-----:99
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to enter into a contract with the National Academy of Medicine (formerly known as the Institute of Medicine) to study and report on the status of data on the health status of members of the National Birth Cohort.
Requires the Director of the CDC to: (1) enter into a cooperative agreement with the National Institute of Diabetes and Digestive and Kidney Diseases to conduct a study to review the status of data on the health status of members of the National Birth Cohort, and (2) report to the Congress on such study.
